Pharmafile Logo
Pharmafocus logo
Advanced Search

Bayer invests 35m euros in biologics production

December 14, 2010
Manufacturing and Production Bayer, Germany, biologics, clinical trials supplies, pharma production

Bayer HealthCare is ramping up its biologics production capacity with the building of a new facility in Wuppertal, Germany, that …

News

GSK buys sports nutrition company for £162m

December 14, 2010
Sales and Marketing GSK, GlaxoSmithKline, Maximuscle, Maxinutrition, consumer healthcare, sports nutrition

GlaxoSmithKline has acquired UK sports nutrition firm Maxinutrition for £162 million to help broaden its consumer portfolio. The company already …

News
Pfizer's New York headquarters

Pfizer withdraws hypertension drug Thelin

December 14, 2010
Sales and Marketing PAH, Pfizer, Thelin, liver damage, liver toxicity, patient safety, pulmonary arterial hypertension, sitaxentan

Pfizer has suffered a blow to its drug development programme with the withdrawal of pulmonary arterial hypertension (PAH) brand Thelin …

News

McNeil recalls Rolaids on particle contamination

December 14, 2010
Manufacturing and Production J&J, JJ, McNeil, Rolaids, particulate contamination, pharmaceutical manufacturing, product recalls

Recalls at Johnson & Johnson are coming thick and fast at the moment. In the latest incident the firm’s troubled …

News

Sopharma breaks ground on 16th manufacturing plant

December 14, 2010
Manufacturing and Production Bulgaria, Sopharma, oral dosage forms, pharma manufacturing, pharmaceutica production

Bulgarian drugmaker Sopharma says it will press ahead with plans to build a new production plant for oral dosage forms …

News

Sanofi extends Genzyme share deal deadline

December 14, 2010
Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, Sanofi-Aventis, mergers and acquisitions, pharma acquisitions

Sanofi-Aventis has extended the deadline to acquire Genzyme after the US biotech’s shareholders have so far proved immune to its …

News
Amgen HQ

Amgen and Actelion meet to “talk takeover”

December 13, 2010
Research and Development, Sales and Marketing Acelion, Amgen, pharma acquisitions, takeover

Amgen has met with Actelion to discuss a potential takeover but has not yet made a bid for the Swiss …

News

Novartis pulls Zometa submission after breast cancer failure

December 13, 2010
Research and Development, Sales and Marketing Novatis, Zometa, breast cancer, zoledronic

Novartis has pulled Zometa’s marketing application for an early breast cancer indication after the drug failed to meet its primary …

News

China to ‘overtake US in innovation by 2020’

December 13, 2010
Research and Development, Sales and Marketing AstraZeneca, China, India, innovation

China will replace the US as the number one ‘powerhouse of innovation’ within the next ten years according to a …

News

Bristol-Myers Squibb appoints new UK general manager

December 13, 2010
Manufacturing and Production, Research and Development, Sales and Marketing Amadou Diarra, BMS, Bristol-Myers Squibb, appointment, recruitment, sales and marketing

Bristol-Myers Squibb has appointed Amadou Diarra as general manager of its UK company, where he will be in charge of …

News

West Pharma cuts staff as profits are pressured

December 13, 2010
Manufacturing and Production West Pharma, drug delivery systems, job cuts, pharma packaging, pharmaceutical manufacturing, plastic packaging

West Pharmaceutical Services has taken the axe to its manufacturing facilities in the US and UK in order to cut …

News

Contract manufacturing driving Indian bulk drugs market

December 13, 2010
Manufacturing and Production Cygnus, Drug Master Files, India, Indian pharmaceutical industry, contract manufacturing

The Indian bulk drug industry is expected to expand at an annual growth rate of 21% to reach $16.91 billion …

News

Pfizer: WikiLeaks claims “preposterous”

December 10, 2010
Research and Development Nigeria, Pfizer, Trovan, WikiLeaks, ceftriaxone, clinical trial safety, industry reputation

Pfizer has dimissed as “preposterous” the claims it hired investigators to uncover evidence of corruption by a top government official …

News
Dr Steve Yang

Double blow to Pfizer’s emerging markets strategy

December 10, 2010
Business Services, Sales and Marketing David Simmons, Ian Read, Jean-Michel Halfon, Jeffrey Kindler, Pfizer, Steve Yang, emerging pharma markets, recruitment

Pfizer has lost two senior executives with key roles in its emerging markets strategy. The departure of the company’s head …

News

Hormone therapy drugs ‘increase heart disease risk’

December 10, 2010
Research and Development AstraZeneca, Hormone therapy, Novartis, Pfizer, aromatase inhibitors, breast cancer, tamoxifen

Three aromatase inhibitors could increase the risk of heart disease in postmenopausal women with breast cancer, according to new data. …

News

Elan names Robert Ingram as new chairman

December 10, 2010
Research and Development, Sales and Marketing Elan, appointment, research and development, sales and marketing

Elan has appointed former Glaxo Wellcome chief executive Robert Ingram as its chairman-designate. Ingram led Glaxo between 1997 and 2000 …

Appointment

Valuing medicines and NHS reform – the ABPI view

December 10, 2010
Sales and Marketing ABPI, NHS reforms, Paul Catchpole, market access, value-based pricing

For those concerned with improving the value for money of medicines to the UK’s health service, the government’s White Paper …

Feature

Boehringer puts afatinib head-to-head with Herceptin

December 10, 2010
Research and Development BIBW 2992, Boehringer Ingelheim, Herceptin, Roche, Tovok, afatinib, breast cancer

Boehringer Ingelheim has set up a showdown between one of its pipeline oncology products and Roche’s Herceptin. It has started …

News

SHL Establishes New Facility in the USA for Final Assembly and Packaging of Auto-Injectors

December 10, 2010
Manufacturing and Production auto injector, autoinjector, final assembly, packaging, shl

SHL, a leading manufacturer of drug delivery devices, will further expand operations in the USA with the establishment of SHL …

News
Press release

Roche highlights R&D promise after setbacks

December 9, 2010
Research and Development MS, Roche, oncology, personalised medicine, schizophrenia

Roche has presented its pipeline to shareholders to boost confidence that it can sustain the spectacular growth of recent years. …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026